CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS

Similar documents
Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Pharmacology in the Elderly

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS

Geriatric Pharmacology

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX

Prescribing Drugs to the Elderly

Public Dissemination Effective: January 2018

Pharmaceutical Care for Geriatrics

Disclosure and Acknowledgements

Polypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Physical and Sensory Changes in the Older Adult: Considerations for Medication Management

4/26/2012. Laura Grooms, MD Assistant Professor Geriatric Medicine Department of Family and Geriatric Medicine University of Louisville April 20, 2012

2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY OVERALL PRESCRIBING

2/26/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS

Index. Note: Page numbers of article titles are in boldface type.

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

Perfect Endings. Home Alone. Senior Estimate. Staying Alive. Medication Madness

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

Research on medication in the geriatric health services facility Abstracts

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

CHCS. Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia. Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES

Prescribing for older people

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit

MANAGING DRUG USE IN THE ELDERLY. General practitioners adherence to guidelines and patients conceptions of medication

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

Deprescribing: the good, the bad, the ugly

Southern Trust Anticoagulant Team

Western University of Health Sciences, College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care

Aspirin and Sta,ns and Benzos! Oh My! Polypharmacy in the Older Adult

Pitfalls in Pharmacotherapy of Geriatrics

Medicines in Older People- Some of the Key Issues

Prescribing in the Elderly. Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry

Multidisciplinary Geriatric Trauma Care Guideline

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork

HEALTH PROFESSIONAL V BAYER

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

From medicines reconciliation to medicines review. Dr. Fatma Karapinar Hospital pharmacistepidemiologist

Rebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L.

Objectives. Case Ruby. 1- Warfarin. 1- Warfarin. Warfarin discontinuation 8/13/ DRUGS TO STOP GIVING HOSPICE PATIENTS

Test Bank for Ebersole and Hess Toward Healthy Aging Human Needs and Nursing Response 8th Edition by Touhy and Jett

Edoxaban Switch Programme - Frequently Asked Questions

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

4/26/2016 DISCLOSURES BACKGROUND OBJECTIVES BACKGROUND BACKGROUND

Medication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island

Interdisciplinary detection of potential drug related problems in older people

Screening tools for elderly patients in primary care

DRUGS, PREGNECY & NEWBORN

Why New Thinking is Needed for Older Adults across the Rehabilitation Continuum

Supplementary Online Content

Update in Geriatrics: Choosing Wisely Primum Non Nocere

An approach to prescribing in the elderly. Preamble

Biology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation.

CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting

2016 General Practice/Family Practice Preferred Specialty Measure Set

Aging Changes That Impact Medication Management

Polypharmacy. A CPPE distance learning programme

Bugs, Drugs and In the News: Recently Approved Drugs ANNESHA WHITE, PHARMD, MS, PHD UNIVERSITY OF NORTH TEXAS SYSTEM COLLEGE OF PHARMACY

Are Pediatric Patients Small Adults?

Medication Management. Medications: The Right Balance. Who are we talking about? Geriatric Syndromes 9/19/2016. Older adults are a heterogenous group!

Prescribing and Pharmacokinetic Considerations in the Elderly

Deprescribing with Confidence Dr Sanjay Suman MD FRCP

Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia

cardiovascular risk in elderly people Managing DECISION TO PRESCRIBE keyword: elderlycardio What am I trying to achieve?

Objectives. Polypharmacy Seminar. Causes of Polypharmacy. Polypharmacy 8/05/12. National Prescribing Curriculum Module

Polypharmacy and Deprescribing for Older People

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

Atrial Fibrillation Implementation challenges. Lesley Edgar Ross Maconachie

7:30 a.m. 8:05 a.m. Welcome/Introductions and Tips for Success

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY

Polypharmacy, whose problem, whose responsibility? Catherine Gerard & Les Toop

A. Definition. B. Epidemiology. C. Classification. i. Pharmacokinetic DIs. ii. Pharmacodynamic DIs. D. Recognition. E. Prevention

Medicines save lives

Management of Drug Related Hospital Admissions

Healthcare Transformation: Translating Aspiration into Action. Charlotte Yeh, MD Chief Medical Officer, AARP Services, Inc.

La terapia non anticoagulante nel paziente con FA secondo le Linee Guida F. CONROTTO

TAKING YOUR SHARE IN BEHAVIORAL HEALTH HOME CARE

Appropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board

Safe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists

Preventing Falls in Older Adults A Matter of Safety

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018

Effects of Liver Disease on Pharmacokinetics Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program November 4, 2010 National

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives

Effects of Liver Disease on Pharmacokinetics Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program October 29, 2015 National

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD

Transcription:

CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS 1. The following is an accurate description of the aging population: A. The number of older adults will reach 17 million in 2030 B. The ratio of women to men will no longer exist C. The surviving baby boomers will be more racially diverse than previous elders D. The surviving baby boomers will have less financial resources than previous elders E. The minority elder populations are projected to decrease in 2020 2. Education and health literacy in the older Americans can be described as: A. In 2007, 62% of Hispanic elders had high school degrees B. Nearly 20% of people 75 years and older have low health literacy C. In 2007, 62% of black elders had high school degrees D. Nearly 40% of people 75 years and older have low health literacy E. None of the above 3. Following are common chronic conditions older Americans have: A. Diabetes, hypertension, cancer B. Hypertension, Alzheimer disease, Parkinson disease C. Asthma, stroke, hypothyroidism D. Chronic lower respiratory diseases, Alzheimer disease, stroke E. Cancer, heart disease, Parkinson disease 4. The most important pharmacokinetic change that occurs with aging is: A. Reduced renal function B. Delayed gastric emptying

C. Increased conjugation D. Phase II hepatic metabolism E. Deconditioning 5. All of the following are incorporated into the Cockcroft Gault equation except: A. Age B. Gender C. Serum albumin D. Serum creatinine E. Weight 6. Because of pharmacodynamic changes, older adults have increased sensitivity to: A. Acetaminophen B. Metformin C. Aspirin D. Morphine E. Cyanocobalamin 7. Polypharmacy use in older adults does not result in: A. Increased adherence B. Increased drug drug interaction C. Increased complex regimen D. Increased hospitalization E. Increased health care cost 8. According to the 2012 Beers criteria, the following drug should be avoided in older adults: A. Diazepam

B. Warfarin C. Aspirin D. Pravastatin E. Mirtazapine 9. The following statement about pain in older adults is true: A. Older adults do not feel as much pain as younger adults. B. Older adults experience less addiction when using opioids for nerve pain. C. Pain is not a quality indicator in long-term care facilities because it is not an objective measure. D. Pain is frequently undertreated and underreported in elders. E. Elders are more comfortable with opioid use because they are closer to end of life. 10. The predictors of adverse drug reactions include the following except: A. More than four medications B. Longer than 14 days of hospital stay C. More than four active medical problems D. Smoking history E. History of alcohol use 11. Medication nonadherence among older adults is influenced by: A. More than two prescribers B. Four or more medication changes in past 12 months C. History of more than two surgeries D. Having no caregiver help E. More than two chronic conditions for at least 10 years

12. Anticoagulation therapy in older adults: A. has proven benefit in atrial fibrillation B. should be withheld due to bleeding side effects C. should be withheld due to fall risks D. is more beneficial in the very sick E. is less beneficial in the community-dwelling ambulatory patient 13. Geriatric assessment: A. should only be performed by a board-certified geriatrician B. is an interprofessional collaborative process C. routinely includes a formal driving evaluation by occupational therapy D. includes history taking from the patient alone without family for maximum privacy E. is usually done at the hospital during an acute admission 14. Quality indicators: A. monitor costs related to pressure ulcer formation in long-term care facilities B. are used to measure the environmental quality of outpatient geriatric clinics C. do not include subjective complaints such as pain D. focus on physical health issues and do not include mental health issues E. are used by facility administrators and government overseers to identify problem areas 15. The following statement about pharmacotherapy in older adults is false: A. Renal function needs to be monitored for patients on digoxin. B. Beers criteria indicate inappropriate medications.

C. Benzodiazepines may cause significant adverse effects. D. Albumin needs to be monitored for patients on phenytoin. E. Drug monitoring is often unnecessary due to multimorbidity. Answers 1. C 2. D 3. A 4. A 5. C 6. D 7. A 8. A 9. D 10. D 11. B 12. A 13. B 14. E 15. E